Phenicol antibacterials
US-9073894-B2 · Jul 7, 2015 · US
US9340564B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9340564-B2 |
| Application number | US-201514731650-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 5, 2015 |
| Priority date | Mar 6, 2012 |
| Publication date | May 17, 2016 |
| Grant date | May 17, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides novel phenicol derivatives, their use for the treatment of infections in mammals, pharmaceutical composition containing these novel compounds, and methods for the preparation of these compounds.
Opening claim text (preview).
We claim: 1. A method for controlling or treating infections in livestock by administering to an animal in need of a therapeutically effective amount of a compound of Formula II, its enantiomers, diastereomers, or pharmaceutically acceptable salts thereof wherein W is —H or —PO(OH)2; and X and Y are each independently halo. 2. The method of claim 1 wherein X and Y are both fluoro. 3. The method of claim 1 wherein the livestock is cattle or swine. 4. The method of claim 3 wherein the livestock is cattle. 5. The method of claim 1 wherein the compound of Formula II is N-(1-(4-(6-(1- aminoethyl)pyridin-3-yl)phenyl)-3-fluoro-1-hydroxyprop an-2-yl)-2,2-difluoroacetamide, its enantiomers, diastereomers, or pharmaceutically acceptable salt thereof. 6. The method of claim 5 wherein the compound of Formula II is N-(( 1R,2S)-1-(4-(6-(RS)-1-aminoethyl)pyridin-3-yl)phenyl)-3-fluoro-1-hydroxypropan-2-yl)-2,2-difluoroacetamide or (1R,2S)-1-(4-(6-(RS)-1-aminoethyl)pyridin-3-yl)phenyl)-2-(2,2-difluoroacetamido )-3-fluoropropyl dihydrogen phosphate. 7. The method of claim 6 wherein the compound of Formula II is N-(( 1R,2S)-1-(4-(6-((S)-1-aminoethyl)pyridin-3-yl)phenyl)-3-fluoro-1-hydroxypropan-2-yl)-2,2-difluoroacetamide or (1R,2S)-1-(4-(6-((S)-1- aminoethyl)pyridin-3-yl)phenyl)-2- (2,2-difluoroacetamido)-3-fluoropropyl dihydrogen phosphate. 8. The method of claim 1 wherein the compound of Formula II is selected from: N-((1R,2S)-1-(4- (6- (1- aminoethyl)pyridin-3-yl)phenyl)-3-fluoro-1-hydroxypropan-2-yl)-2,2-dichloroacetamide; (1R,2S)-1-(4- (6- (1-aminoethyl)pyridin-3-yl)phenyl)-2-(2,2-dichloroacetamido)-3-fluoropropyl hydrogen phosphate sodium; (1R,2S)-1-(4-(6- (1- aminoethyl)pyridin-3-yl)phenyl)-2-(2,2-dichloroacetamido)-3-fluoropropyl dihydrogen phosphate; (1R,2S)-1-(4- (6-(1-aminoethyl)pyridin-3-yl)phenyl)-2-(2,2-difluoroacetamido)-3-fluoropropyl hydrogen phosphate sodium; and (1R,2S)-1-(4-(6-(1- aminoethyl)pyridin-3-yl)phenyl)-2-(2,2-difluoroacetamido)-3-fluoropropyl dihydrogen phosphate. 9. The compound N4(1R,2S)-1-(4-(6-(1-aminocyclopropyl)pyridin-3-yl) phenyl)-3-fluoro-1-hydroxypropan-2-yl)-2,2-difluoroacetamide, its enantiomers, diastereomers, or a pharmaceutically acceptable salt thereof.
with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms · CPC title
having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom · CPC title
Ortho-condensed systems · CPC title
linked by a carbon chain containing only aliphatic carbon atoms · CPC title
directly linked by a ring-member-to-ring-member bond · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.